| Fired From KaloBios, Shkreli Defends Himself Against Fraud Charges | Alex Lash | 12/21/15 | National |
| The Day After His Arrest, Martin Shkreli Is Out At Turing Pharma | Alex Lash | 12/18/15 | National |
| West Coast Bio Roundup: Shkreli Cuffed, KaloBios Halted & More | Alex Lash | 12/17/15 | National |
| West Coast Bio Roundup: Gene Edit Talk, Not Poor ORIC, BioMarin Sags | Alex Lash | 12/04/15 | San Francisco |
| West Coast Bio Roundup: Shkreli, T4 Diabetes, Cella-Done, A16Z+Bio | Alex Lash | 11/20/15 | San Diego |
| Even With New Crowdfunding Rules, No Easy Path Forward For Biotechs | Alex Lash | 11/03/15 | National |
| Biopharma CEOs, VCs, and Hedge Fund Managers: Fifty Shades of Greed | Stewart Lyman | 10/07/15 | National |
| Crossing Sand Hill: A Q&A With Biotech Venture Vet Nina Kjellson | Alex Lash | 09/30/15 | San Francisco |
| West Coast Biotech Roundup: Gilead, Conatus, Exelixis, and More | Bruce V. Bigelow | 09/25/15 | San Diego |
| Shkreli Implodes And Provides Hillary A Perfect Medicare Moment | Alex Lash | 09/23/15 | National |
| East Coast Biotech Roundup: CAR-T, Celgene, Aerie, ITCI, IPOs, & More | Ben Fidler | 09/21/15 | Boston |
| East Coast Biotech Roundup: WaVe, Shkreli, Intarcia & More | Ben Fidler | 08/21/15 | Boston |
| East Coast Biotech Roundup: Editas, Checkmate, Ovid & More | Ben Fidler | 08/14/15 | Boston |
| Shkreli Leads $90M Round for New Startup, Turing Pharma | Ben Fidler | 08/10/15 | New York |
| With Asklepion Deal, Retrophin Gets a New Drug—And a Voucher | Ben Fidler | 03/18/15 | New York |
| East Coast Biotech Roundup: Raze, Retrophin, Alnylam, & More | Ben Fidler | 10/16/14 | Boston |
| East Coast Biotech Roundup: Maraganore, Flex, NPS, Retrophin, & More | Ben Fidler | 09/15/14 | Boston |
| East Coast Biotech Roundup: Emulate, Accelerator, Retrophin, & More | Ben Fidler | 08/01/14 | Boston |
| With $2M Seed, Perlstein Lab Tests Unorthodox Rare-Disease Plan | Alex Lash | 07/31/14 | San Francisco |
| Retrophin Shares Boom Following Manchester Pharma Buyout | Ben Fidler | 02/13/14 | New York |
| East Coast Biotech Roundup: Curoverse, Sia, Trinity, & (Much) More | Ben Fidler | 12/20/13 | Boston |
| East Coast Biotech Roundup: ASH, Proteostasis, Retrophin, & More | Ben Fidler | 12/13/13 | Boston |
| East Coast Life Sciences Roundup: NY Genome Center, Acceleron, Bind, & More | Ben Fidler | 09/20/13 | Boston |
| Shkreli’s Retrophin Makes Hostile Bid For CA-based Transcept | Ben Fidler | 09/18/13 | New York |
| Retrophin, Headed by Controversial Hedge Fund Chief, Raises $4M | Arlene Weintraub | 05/07/12 | New York |
| Hard-Nosed Hedge Fund Chief Has Soft Spot for Rare-Disease Startup | Arlene Weintraub | 04/03/12 | New York |
